BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 38029224)

  • 1. Research Progress on the Mechanism and Management of Septic Cardiomyopathy: A Comprehensive Review.
    Pei XB; Liu B
    Emerg Med Int; 2023; 2023():8107336. PubMed ID: 38029224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of sepsis-induced cardiomyopathy.
    Hollenberg SM; Singer M
    Nat Rev Cardiol; 2021 Jun; 18(6):424-434. PubMed ID: 33473203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Mechanisms in Septic Cardiomyopathy.
    Cimolai MC; Alvarez S; Bode C; Bugger H
    Int J Mol Sci; 2015 Aug; 16(8):17763-78. PubMed ID: 26247933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress on the mechanism of ferroptosis in septic cardiomyopathy].
    Song J; He Y; Zhou K; Xue J; Zi X; Li L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Oct; 34(10):1107-1111. PubMed ID: 36473574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and deduction in sepsis-induced cardiomyopathy: five typical categories.
    Wang J; Wang XT; Liu DW; Zhang HM; Su LX
    Chin Med J (Engl); 2020 Sep; 133(18):2205-2211. PubMed ID: 32881720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress of mechanisms of oxidative stress in septic cardiomyopathy].
    Peng S; Zhou L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1337-1341. PubMed ID: 36567595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Sepsis on Myocardial Function: A Review of Pathophysiology, Diagnostic Criteria, and Treatment.
    Khalid N; Patel PD; Alghareeb R; Hussain A; Maheshwari MV
    Cureus; 2022 Jun; 14(6):e26178. PubMed ID: 35891864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of toll-like receptor-mediated pyroptosis in sepsis-induced cardiomyopathy.
    Fan Y; Guan B; Xu J; Zhang H; Yi L; Yang Z
    Biomed Pharmacother; 2023 Nov; 167():115493. PubMed ID: 37734261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Septic cardiomyopathy: pathophysiology and potential new therapeutic approaches].
    Suzuki T; Sakai M; Yamashita S; Tomita K; Hattori Y
    Nihon Yakurigaku Zasshi; 2018; 151(3):111-116. PubMed ID: 29526919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Plasma Histone H4 Levels Are an Important Risk Factor in the Development of Septic Cardiomyopathy.
    Lu NF; Jiang L; Zhu B; Yang DG; Zheng RQ; Shao J; Yuan J; Xi XM
    Balkan Med J; 2020 Feb; 37(2):72-78. PubMed ID: 31674172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Mitochondrial Disorders in Septic Cardiomyopathy.
    Durand A; Duburcq T; Dekeyser T; Neviere R; Howsam M; Favory R; Preau S
    Oxid Med Cell Longev; 2017; 2017():4076348. PubMed ID: 29201271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Septic Cardiomyopathy.
    Beesley SJ; Weber G; Sarge T; Nikravan S; Grissom CK; Lanspa MJ; Shahul S; Brown SM
    Crit Care Med; 2018 Apr; 46(4):625-634. PubMed ID: 29227368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analysis of Whole Transcriptome Profiles in Septic Cardiomyopathy: Insights from CLP- and LPS-Induced Mouse Models.
    Ullah K; Li Y; Lin Q; Pan K; Nguyen T; Aniruddhsingh S; Su Q; Sharp W; Wu R
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic mechanisms of septic cardiomyopathy.
    Wang R; Xu Y; Fang Y; Wang C; Xue Y; Wang F; Cheng J; Ren H; Wang J; Guo W; Liu L; Zhang M
    J Cell Physiol; 2022 Jan; 237(1):49-58. PubMed ID: 34278573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy Metabolism: From Physiological Changes to Targets in Sepsis-induced Cardiomyopathy.
    Ni D; Lin X; Deng C; Yuan L; Li J; Liu Y; Liang P; Jiang B
    Hellenic J Cardiol; 2024 May; ():. PubMed ID: 38734307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications.
    Martin L; Derwall M; Al Zoubi S; Zechendorf E; Reuter DA; Thiemermann C; Schuerholz T
    Chest; 2019 Feb; 155(2):427-437. PubMed ID: 30171861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis-related cardiomyopathy: Not an easy task for ICU physicians.
    Zhang H; Liu D
    J Intensive Med; 2022 Oct; 2(4):257-259. PubMed ID: 36788939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis on sarcoglycans expression as markers of septic cardiomyopathy in sepsis-related death.
    Ventura Spagnolo E; Mondello C; Di Mauro D; Vermiglio G; Asmundo A; Filippini E; Alibrandi A; Rizzo G
    Int J Legal Med; 2018 Nov; 132(6):1685-1692. PubMed ID: 29644391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis‑induced cardiac dysfunction and pathogenetic mechanisms (Review).
    Song J; Fang X; Zhou K; Bao H; Li L
    Mol Med Rep; 2023 Dec; 28(6):. PubMed ID: 37859613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.